Porphyrias
Top Cited Papers
- 1 March 2010
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 375 (9718) , 924-937
- https://doi.org/10.1016/s0140-6736(09)61925-5
Abstract
No abstract availableKeywords
Funding Information
- Public Health and Consumer Protection Directorate Public Health Executive Agency (ANR-07-MRAR-008-01)
This publication has 123 references indexed in Scilit:
- RETRACTED: Peroxisome Proliferator-Activated Receptor α Controls Hepatic Heme Biosynthesis Through ALAS1Journal of Molecular Biology, 2009
- Down-regulation of hepcidin in porphyria cutanea tardaBlood, 2008
- C-Terminal Deletions in the ALAS2 Gene Lead to Gain of Function and Cause X-linked Dominant Protoporphyria without Anemia or Iron OverloadPublished by Elsevier ,2008
- Effective Gene Therapy of Mice with Congenital Erythropoietic Porphyria Is Facilitated by a Survival Advantage of Corrected Erythroid CellsAmerican Journal of Human Genetics, 2008
- Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyriasBritish Journal of Clinical Pharmacology, 2007
- A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tardaProceedings of the National Academy of Sciences, 2007
- ALAD Porphyria Is a Conformational DiseaseAmerican Journal of Human Genetics, 2007
- Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyriaBlood, 2006
- Congenital erythropoietic porphyriaPublished by Elsevier ,1997
- Decreased Activity of Hepatic Uroporphyrinogen Decarboxylase in Sporadic Porphyria Cutanea TardaNew England Journal of Medicine, 1978